Submit Deal

Crosstree Capital

Summary

Edit Data

Crosstree is a distinguished boutique investment banking firm.

Market Context

Deals Overview

Edit Data

Total Deals9

Valued Deals1

Total Value£ 73 M

Avg. Deal Size£ 73 M

15 Mar 2024|France|Pharmaceuticals

Target: CREAPHARM (PHARMACEUTICAL SERVICES BUSINESS)

Bidder: MYONEX

9 Service Providers

4 Bidder | 5 Vendor

3 Dealmakers

2 Bidder | 1 Vendor

n/a

Value

06 Sep 2023|Canada|Management Consulting

Target: CREO

Bidder: GRANT AVENUE CAPITAL

5 Service Providers

2 Target | 3 Bidder

10 Dealmakers

7 Target | 3 Bidder

n/a

Value

13 Jan 2022|United States|Software

Target: REALTIME SOFTWARE SOLUTIONS

Bidder: LLR PARTNERS INC

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

n/a

Value

09 Jan 2022|United States|Biotechnology

Target: PREVENTIONGENETICS

Bidder: EXACT SCIENCES

6 Service Providers

3 Target | 3 Bidder

11 Dealmakers

8 Target | 3 Bidder

n/a

Value

14 Oct 2021|United States|Medical Services

Target: EXCEL MEDICAL CLINICAL TRIALS

Bidder: FLOURISH RESEARCH

5 Service Providers

2 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

n/a

Value

12 Aug 2021|United States|Medical Services

Target: CLINICAL TRIALS OF TEXAS

Bidder: NMS CAPITAL

5 Service Providers

3 Target | 2 Bidder

4 Dealmakers

1 Target | 3 Bidder

n/a

Value

06 Aug 2021|United States|Biotechnology

Target: NAVITAS LIFE SOLUTIONS

Bidder: HIG CAPITAL LLC

10 Service Providers

4 Bidder | 6 Vendor

8 Dealmakers

4 Bidder | 4 Vendor

£ 73 M

Value

04 Sep 2019|United States|Pharmaceuticals

Target: CURETIS

Bidder: OPGEN

6 Service Providers

3 Target | 3 Bidder

3 Dealmakers

2 Target | 1 Bidder

n/a

Value

31 Jul 2019|United States|Biotechnology

Target: HISTOGENEX

Bidder: CAPRION BIOSCIENCES

9 Service Providers

2 Target | 7 Bidder

14 Dealmakers

3 Target | 11 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy